Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
Duke Univ Med Ctr
mi
from
Durham, NC
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
Virginia Commonwealth University
mi
from
Richmond, VA
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
University of California at San Francisco
mi
from
San Francisco, CA
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated:  3/12/2018
St. Louis University
mi
from
Saint Louis, MO
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in Nonalcoholic Steatohepatitis (NASH) Treatment (FLINT) Trial
Status: Enrolling
Updated: 3/12/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Institute for Advanced Wound Care
mi
from
Montgomery, AL
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Institute for Advanced Wound Care
mi
from
Montgomery, AL
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
ILD Research Center
mi
from
Carlsbad, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
ILD Research Center
mi
from
Carlsbad, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Center for Clinical Research
mi
from
Castro Valley, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Fairfield County Foot Surgeons
mi
from
Norwalk, CT
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Fairfield County Foot Surgeons
mi
from
Norwalk, CT
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Andrews Research and Education Institute
mi
from
Gulf Breeze, FL
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Andrews Research and Education Institute
mi
from
Gulf Breeze, FL
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Rosalind Franklin University, CLEAR
mi
from
North Chicago, IL
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Rosalind Franklin University, CLEAR
mi
from
North Chicago, IL
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Boston Medical College
mi
from
Boston, MA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Boston Medical College
mi
from
Boston, MA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
Wound Institute and Reseach Center
mi
from
Dunmore, PA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
Wound Institute and Reseach Center
mi
from
Dunmore, PA
Click here to add this to my saved trials
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated:  3/12/2018
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
DermACELL in Subjects With Chronic Wounds of the Lower Extremities
A Multicenter, Randomized, Controlled, Open Label Trial of DermACELL in Subjects With Chronic Wounds of the Lower Extremities
Status: Enrolling
Updated: 3/12/2018
VA Pittsburgh Healthcare System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
University of California, San Diego
mi
from
San Diego, CA
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
University of California at San Francisco
mi
from
San Francisco, CA
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
Indiana University
mi
from
Indianapolis, IN
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
St. Louis University
mi
from
Saint Louis, MO
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated:  3/12/2018
Univ of Washington
mi
from
Seattle, WA
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Clinical Research Network in Nonalcoholic Steatohepatitis: Pioglitazone vs. Vitamin E vs. Placebo for the Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Status: Enrolling
Updated: 3/12/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Status: Enrolling
Updated:  3/13/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Status: Enrolling
Updated: 3/13/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Utility of an Animated Bowel Biofeedback Training Routine to Improve Bowel Function in Individuals With SCI
Bowel Biofeedback Training to Improve Bowel Function in Individuals With SCI
Status: Enrolling
Updated:  3/13/2018
James J. Peters VA Medical Center, Bronx, NY
mi
from
Bronx, NY
Utility of an Animated Bowel Biofeedback Training Routine to Improve Bowel Function in Individuals With SCI
Bowel Biofeedback Training to Improve Bowel Function in Individuals With SCI
Status: Enrolling
Updated: 3/13/2018
James J. Peters VA Medical Center, Bronx, NY
mi
from
Bronx, NY
Click here to add this to my saved trials
Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease
Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/13/2018
National University of Natural Medicine
mi
from
Portland, OR
Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease
Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/13/2018
National University of Natural Medicine
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
9171 West Thunderbird Road
mi
from
Peoria, AZ
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
9171 West Thunderbird Road
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
850 North Kolb Road
mi
from
Tucson, AZ
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
850 North Kolb Road
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
11219 Financial Centre Parkway
mi
from
Little Rock, AR
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
11219 Financial Centre Parkway
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
13055 Southwest 42nd Street
mi
from
Miami, FL
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
13055 Southwest 42nd Street
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
8200 Southwest 117th Avenue
mi
from
Miami, FL
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
8200 Southwest 117th Avenue
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
125 Clairemont Avenue
mi
from
Decatur, GA
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
125 Clairemont Avenue
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
616 South Washington Street
mi
from
Bastrop, LA
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
616 South Washington Street
mi
from
Bastrop, LA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
6035 Shallowford Road
mi
from
Chattanooga, TN
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
6035 Shallowford Road
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated:  3/13/2018
26 Stonecreek Circle
mi
from
Jackson, TN
A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis
Status: Enrolling
Updated: 3/13/2018
26 Stonecreek Circle
mi
from
Jackson, TN
Click here to add this to my saved trials
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
Growth and the Effect of Genotropin in Chronically Ill Children With Juvenile Rheumatoid Arthritis and With Crohn's Disease
Status: Enrolling
Updated:  3/14/2018
Columbus Children's Hospital
mi
from
Columbus, OH
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
Growth and the Effect of Genotropin in Chronically Ill Children With Juvenile Rheumatoid Arthritis and With Crohn's Disease
Status: Enrolling
Updated: 3/14/2018
Columbus Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Proton Pump Inhibitors and Dysbiosis in Cirrhosis
Status: Enrolling
Updated:  3/14/2018
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Proton Pump Inhibitors and Dysbiosis in Cirrhosis
Status: Enrolling
Updated: 3/14/2018
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Vitamin D Repletion in Primary Hyperparathyroidism
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
Status: Enrolling
Updated:  3/15/2018
Columbia University Medical Center
mi
from
New York, NY
Vitamin D Repletion in Primary Hyperparathyroidism
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
Status: Enrolling
Updated: 3/15/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease
Evaluation of Combined Endoscopic Ultrasound Ductal Evaluation Before & After Secretin Stimulation in One EUS Session for the Diagnosis of Exocrine Pancreas Disease
Status: Enrolling
Updated:  3/15/2018
Indiana University; University Hospital
mi
from
Indianapolis, IN
EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease
Evaluation of Combined Endoscopic Ultrasound Ductal Evaluation Before & After Secretin Stimulation in One EUS Session for the Diagnosis of Exocrine Pancreas Disease
Status: Enrolling
Updated: 3/15/2018
Indiana University; University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Vitamin D Repletion and Maintenance in IBD: How Much and How Often
A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity
Status: Enrolling
Updated:  3/19/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Vitamin D Repletion and Maintenance in IBD: How Much and How Often
A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity
Status: Enrolling
Updated: 3/19/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated:  3/20/2018
Yale University
mi
from
New Haven, CT
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated: 3/20/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated:  3/20/2018
Indiana University
mi
from
Indianapolis, IN
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated: 3/20/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated:  3/20/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated: 3/20/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated:  3/20/2018
Medical University of South Carolina Digestive Disease Center
mi
from
Charleston, SC
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated: 3/20/2018
Medical University of South Carolina Digestive Disease Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated:  3/20/2018
Methodist Dallas Medical Center
mi
from
Dallas, TX
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated: 3/20/2018
Methodist Dallas Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated:  3/20/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
Status: Enrolling
Updated: 3/20/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials